Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study examined various causes of hair loss in children and found that factors like malnutrition, poor grooming habits, and stress were common, with acquired non-scarring alopecia being prevalent.

This case study reported that growth hormone therapy dramatically improved rickets symptoms and growth in three children with vitamin-D dependent rickets type 2 who had not responded to standard treatments.

Monitoring nutrition and health is crucial for the well-being of institutionalized mentally retarded children.

Corkscrew hair may be a new sign for quickly diagnosing scalp fungus in black children.

This study found that combining topical and oral pulse corticosteroid therapy for severe alopecia areata in children led to long-lasting hair regrowth, especially in AA plurifocalis, with no serious side effects reported.

This study aimed to identify trichoscopic features that help differentiate between tinea capitis and alopecia areata in children, enhancing diagnosis and treatment decisions visually and non-invasively.

In this study, testosterone and dehydroepiandrosterone in children's hair were strongly correlated, supporting hair as a potential method for measuring these hormones.

This study found that the "flying-wings" expanded scalp flap technique effectively restored hemiscalp defects in children following burns, achieving pleasing aesthetic results and proper hair growth direction with minimal complications.

This case report describes an 11-year-old girl who experienced hot flashes and menarche after taking a Serenoa repens supplement for telogen effluvium, suggesting a possible but uncertain link between the supplement and hormonal changes.

In this study, ritlecitinib was generally well tolerated in pediatric alopecia areata patients aged 6 to <12 years, with no severe or serious adverse events reported, and the drug's pharmacokinetic parameters were successfully characterized.

In this study, Wood's lamp effectively identified tinea capitis among pediatric patients with alopecia, particularly when contact with animals was a factor, supporting its diagnostic use in primary healthcare settings.

In this study, seborrheic dermatitis was most prevalent among middle-aged adults and men, with patient presentations peaking during the winter months.

This meta-analysis reported no significant improvement in muscle strength or mobility with glucocorticoid treatment for progressive muscular dystrophy but observed an increase in adverse effects like acne and emotional irritability.

This study investigated the safety and efficacy of IV iron maltoside 1000 in treating iron-deficiency anemia among children with IBD and found a significant increase in hemoglobin levels by 6 weeks, maintained for up to a year, with minimal side effects reported.

This study observed that in pediatric patients with alopecia areata, severity of the condition was associated with disease duration, atopy, and nail involvement, but not with anemia.

In this study, 10.25% of school children aged 5-15 in Belagavi were found to have premature greying of hair, with the majority showing mild severity according to the Graying Severity Score.

Lower family income is linked to more stress in parents and more behavior problems in children.

In this pediatric retrospective study, tofacitinib (a Janus kinase inhibitor) improved the severity of alopecia and quality of life more effectively than traditional treatment methods, with significant reductions in alopecia severity score and dermatology life quality index over 16 weeks.

In this study, among Chinese infants and young children aged 0-5 years, Type II and Type III frontal hairline patterns were the most common, with a negative correlation observed between age and hairline type.

This review discusses the pathogenesis of alopecia areata and the use of systemic JAK inhibitors in treating severe cases in pediatric patients, highlighting the safety of selective agents for children.

This review found that autoimmune damage is a key factor in alopecia areata, noting its comorbidity with other diseases and the potential of Janus kinase inhibitors in treatment.

In this study, radial shockwave therapy significantly improved muscle spasticity, ankle range of motion, and functional abilities in children with spastic cerebral palsy, suggesting it may help them achieve greater autonomy in daily activities.

This study suggests that potent topical corticosteroid occlusion may be a safe and effective treatment option for pediatric patients with severe alopecia areata, although further research is needed on its long-term safety and recurrence.

This retrospective study found that oral tofacitinib significantly reduced the severity of alopecia areata in children, achieving over a 50% reduction in hair loss severity, though relapse occurred during treatment tapering, and mild adverse effects were noted.

This study found that all four subtypes of psoriasis were associated with a higher prevalence of autoimmune diseases compared to individuals without psoriasis, with variation in the specific autoimmune disorders associated with each subtype.

This study observed that repeated hair follicle sampling is feasible and reliable for measuring FMR1 mRNA and FMRP in individuals with Fragile X syndrome, supporting its use in longitudinal studies.

This study found that repeatedly collecting hair follicles from individuals with fragile X syndrome is feasible for measuring FMR1 and FMRP levels in both home and office settings.

This article provides an overview of Ebola virus disease, focusing on its impact on children and the limited understanding of their disease course, without reporting new clinical findings.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.